American Healthcare REIT (AHR)
Market Price (12/23/2025): $48.15 | Market Cap: $8.1 BilSector: Real Estate | Industry: Health Care REITs
American Healthcare REIT (AHR)
Market Price (12/23/2025): $48.15Market Cap: $8.1 BilSector: Real EstateIndustry: Health Care REITs
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 14% | Trading close to highsDist 52W High is -4.5% | Expensive valuation multiplesP/EBITPrice/EBIT or Price/(Operating Income) ratio is 78x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 27x, P/EPrice/Earnings or Price/(Net Income) is 301x |
| Low stock price volatilityVol 12M is 27% | Key risksAHR key risks include [1] substantial legacy investor losses and valuation concerns stemming from its deeply discounted IPO, Show more. | |
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, and Sustainable & Green Buildings. Themes include Geriatric Care, and Green Building Certification. |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 14% |
| Low stock price volatilityVol 12M is 27% |
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, and Sustainable & Green Buildings. Themes include Geriatric Care, and Green Building Certification. |
| Trading close to highsDist 52W High is -4.5% |
| Expensive valuation multiplesP/EBITPrice/EBIT or Price/(Operating Income) ratio is 78x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 27x, P/EPrice/Earnings or Price/(Net Income) is 301x |
| Key risksAHR key risks include [1] substantial legacy investor losses and valuation concerns stemming from its deeply discounted IPO, Show more. |
Why The Stock Moved
Qualitative Assessment
AI Analysis | Feedback
Here are five key points explaining the approximate 14% movement in American Healthcare REIT (AHR) stock:1. Strong Earnings Performance and Positive Outlook: American Healthcare REIT reported robust financial results, with expectations for continued strong earnings growth in 2025 and 2026. The company increased its full-year 2024 guidance for Normalized Funds from Operations (NFFO) and Same-Store Net Operating Income (NOI) in November 2024, reflecting improved portfolio performance. Specifically, AHR's NFFO growth of +27% year-over-year significantly outpaced the sector average, with an expected forward NFFO growth of +25%.
2. Favorable Demographic Tailwinds: The ongoing aging of the baby boomer population is a significant driver of demand for healthcare real estate. With the oldest baby boomers beginning to turn 80 in 2025, there is increased demand for senior housing, assisted living, skilled nursing, and independent living facilities, leading to higher occupancy rates and revenue across the sector.
Show more
Stock Movement Drivers
Fundamental Drivers
The 15.9% change in AHR stock from 9/22/2025 to 12/22/2025 was primarily driven by a 19.3% change in the company's P/S Multiple.| 9222025 | 12222025 | Change | |
|---|---|---|---|
| Stock Price ($) | 41.86 | 48.50 | 15.87% |
| Change Contribution By | LTM | LTM | |
| Total Revenues ($ Mil) | 2149.66 | 2198.78 | 2.29% |
| P/S Multiple | 3.13 | 3.73 | 19.29% |
| Shares Outstanding (Mil) | 160.50 | 169.01 | -5.30% |
| Cumulative Contribution | 15.54% |
Market Drivers
9/22/2025 to 12/22/2025| Return | Correlation | |
|---|---|---|
| AHR | 15.9% | |
| Market (SPY) | 2.7% | -0.8% |
| Sector (XLRE) | -3.6% | 24.9% |
Fundamental Drivers
The 34.2% change in AHR stock from 6/23/2025 to 12/22/2025 was primarily driven by a 38.8% change in the company's P/S Multiple.| 6232025 | 12222025 | Change | |
|---|---|---|---|
| Stock Price ($) | 36.15 | 48.50 | 34.17% |
| Change Contribution By | LTM | LTM | |
| Total Revenues ($ Mil) | 2111.74 | 2198.78 | 4.12% |
| P/S Multiple | 2.69 | 3.73 | 38.78% |
| Shares Outstanding (Mil) | 156.92 | 169.01 | -7.70% |
| Cumulative Contribution | 33.37% |
Market Drivers
6/23/2025 to 12/22/2025| Return | Correlation | |
|---|---|---|
| AHR | 34.2% | |
| Market (SPY) | 14.4% | 3.2% |
| Sector (XLRE) | -3.7% | 26.5% |
Fundamental Drivers
The 80.1% change in AHR stock from 12/22/2024 to 12/22/2025 was primarily driven by a 108.1% change in the company's P/S Multiple.| 12222024 | 12222025 | Change | |
|---|---|---|---|
| Stock Price ($) | 26.93 | 48.50 | 80.11% |
| Change Contribution By | LTM | LTM | |
| Total Revenues ($ Mil) | 2010.48 | 2198.78 | 9.37% |
| P/S Multiple | 1.79 | 3.73 | 108.13% |
| Shares Outstanding (Mil) | 133.73 | 169.01 | -26.38% |
| Cumulative Contribution | 67.58% |
Market Drivers
12/22/2024 to 12/22/2025| Return | Correlation | |
|---|---|---|
| AHR | 80.1% | |
| Market (SPY) | 16.9% | 36.0% |
| Sector (XLRE) | 1.9% | 53.2% |
Fundamental Drivers
nullnull
Market Drivers
12/23/2023 to 12/22/2025| Return | Correlation | |
|---|---|---|
| AHR | ||
| Market (SPY) | 47.7% | 32.5% |
| Sector (XLRE) | 7.2% | 52.6% |
Price Returns Compared
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| AHR Return | � | � | � | � | � | 73% | � |
| Peers Return | -11% | 8% | -11% | 17% | 28% | 22% | 58% |
| S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 17% | 113% |
Monthly Win Rates [3] | |||||||
| AHR Win Rate | � | � | � | � | 80% | 75% | |
| Peers Win Rate | 62% | 48% | 43% | 57% | 65% | 60% | |
| S&P 500 Win Rate | 58% | 75% | 42% | 67% | 75% | 73% | |
Max Drawdowns [4] | |||||||
| AHR Max Drawdown | � | � | � | � | � | -5% | |
| Peers Max Drawdown | -61% | -12% | -24% | -13% | -11% | -6% | |
| S&P 500 Max Drawdown | -31% | -1% | -25% | -1% | -2% | -15% | |
[1] Cumulative total returns since the beginning of 2020
[2] Peers: WELL, VTR, OHI, DOC, SBRA.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/22/2025 (YTD)
How Low Can It Go
AHR has limited trading history. Below is the Real Estate sector ETF (XLRE) in its place.
| Event | XLRE | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -37.9% | -25.4% |
| % Gain to Breakeven | 61.0% | 34.1% |
| Time to Breakeven | Not Fully Recovered days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -39.3% | -33.9% |
| % Gain to Breakeven | 64.7% | 51.3% |
| Time to Breakeven | 393 days | 148 days |
| 2018 Correction | ||
| % Loss | -13.5% | -19.8% |
| % Gain to Breakeven | 15.7% | 24.7% |
| Time to Breakeven | 43 days | 120 days |
Compare to
In The Past
Real Estate Select Sector SPDR Fund (The)'s stock fell -37.9% during the 2022 Inflation Shock from a high on 12/31/2021. A -37.9% loss requires a 61.0% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth over time.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
AI Analysis | Feedback
Here are 1-2 analogies to describe American Healthcare REIT (AHR):
Public Storage for healthcare real estate.
Simon Property Group for medical offices and senior housing.
AI Analysis | Feedback
- Medical Office Buildings: Provides specialized facilities for physicians and other healthcare professionals to deliver outpatient services.
- Senior Housing Facilities: Offers real estate for independent living, assisted living, and memory care communities for seniors.
- Hospitals: Supplies real estate for acute care, specialty, and post-acute hospital operations.
AI Analysis | Feedback
Major Customers of American Healthcare REIT (AHR)
American Healthcare REIT (AHR) operates as a Real Estate Investment Trust (REIT) and primarily generates revenue by leasing its healthcare-related properties (such as skilled nursing facilities, medical office buildings, senior housing, and hospitals) to healthcare operating companies. Therefore, its major customers are these operator companies, not individuals.
Based on recent investor disclosures (e.g., Q3 2023 Investor Presentation), AHR's largest customers by percentage of total portfolio rents include:
- The Ensign Group, Inc. (Symbol: ENSG)
- Nexus Health Systems (Private company)
- Arbor Health (Private company)
- Regency Integrated Healthcare Services (Private company)
- Saber Healthcare Group (Private company)
AI Analysis | Feedback
nullAI Analysis | Feedback
Danny Prosky, President & CEO
Danny Prosky is the President and Chief Executive Officer of American Healthcare REIT, Inc., and a member of its board of directors. He is a co-founder of American Healthcare Investors ("AHI"), which was the sponsor of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV. Prosky previously served as president, chief operating officer, and director of Griffin-American Healthcare REIT III and IV. He also served as president and chief operating officer of Griffin-American Healthcare REIT II, which merged in December 2014 with NorthStar Realty Finance Corp. (now DigitalBridge) in a transaction valued at approximately $4 billion. His career in healthcare real estate investment spans over 25 years, during which he has been responsible for more than $10 billion in transactions.
Brian Peay, Chief Financial Officer
Brian Peay serves as the Chief Financial Officer of American Healthcare REIT. He previously held the same role with American Healthcare Investors, LLC, Griffin-American Healthcare REIT III, and Griffin-American Healthcare REIT IV. Prior to these roles, he was the chief financial officer of Veritas Investments, Inc., a private real estate investment management company with over $2 billion of assets under management. Peay also served as executive vice president and chief financial officer for Glenborough, LLC, a formerly NYSE-listed REIT, for 15 years, where he was instrumental in the company's strategic direction, including raising approximately $450 million in common stock offerings, $300 million in convertible preferred stock, and $2.5 billion in acquisition financing. He also played a key role in the sale of Glenborough to Morgan Stanley Real Estate Fund.
Gabe Willhite, Chief Operating Officer
Gabe Willhite is the Chief Operating Officer for American Healthcare REIT, Inc. He previously served as executive vice president, general counsel with American Healthcare REIT, Inc., and American Healthcare Investors, LLC. Additionally, he acted as assistant general counsel for transactions for Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV. The merger of these REITs and the business and operations of American Healthcare Investors formed American Healthcare REIT in October 2021.
Stefan Oh, Chief Investment Officer
Stefan Oh serves as the Chief Investment Officer for American Healthcare REIT. His prior roles include executive vice president, investments with American Healthcare REIT and American Healthcare Investors, LLC, as well as senior vice president and executive vice president of acquisitions for Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, respectively. Oh helped launch Griffin-American Healthcare REIT II in 2009, serving as its senior vice president-acquisitions until its $4.0 billion merger with NorthStar Realty Finance Corp. (now DigitalBridge) in December 2014. Throughout his 25-year career, he has been involved in the acquisition of over $13.5 billion of healthcare real estate.
Mark Foster, EVP, General Counsel & Secretary
Mark Foster serves as Executive Vice President, General Counsel, and Secretary of American Healthcare REIT. He brings over 23 years of experience as a corporate and transactional attorney, having represented both public and private real estate companies. Before joining American Healthcare REIT, Foster was a partner at Snell & Wilmer L.L.P., where his practice focused on complex real estate and corporate transactions related to the acquisition, financing, leasing, operation, and disposition of commercial real property assets.
AI Analysis | Feedback
The key risks to American Healthcare REIT (AHR) include:- Disappointing IPO Performance, Legacy Investor Losses, and Valuation Concerns: American Healthcare REIT's initial public offering (IPO) in February 2024 priced shares at $12, significantly below the last estimated Net Asset Value (NAV) of $31.40 per share and the original purchase price of $40 per share for many legacy investors, leading to substantial losses for long-term shareholders. This disparity, along with a pre-IPO third-party tender offer of only $13.15 per share, signaled deep market skepticism about AHR's true valuation and exposed the inherent risks of non-traded REITs, such as illiquidity and lack of transparency.
- Liquidity Constraints and Reduced Shareholder Distributions: The company suspended its share repurchase plan in November 2022, except for limited hardship cases, effectively eliminating liquidity for many investors. Additionally, AHR reduced its quarterly distribution in March 2023, citing the need to preserve liquidity and achieve long-term strategic goals. The company's current ratio of 0.46 and quick ratio of 0.44 also suggest ongoing liquidity constraints.
- Risks Associated with Portfolio Quality, Exposure to Challenging Healthcare Segments, and Historical Underperformance: AHR's portfolio, formed from the merger of Griffin-American Healthcare REIT III and IV and the acquisition of American Healthcare Investors (AHI), includes assets that have historically underperformed industry benchmarks. Specifically, AHI's portfolio primarily consisted of lower-quality skilled nursing facilities (SNFs), a market segment facing significant challenges due to declining occupancy rates and government reimbursement cuts, which could hinder overall growth and profitability.
AI Analysis | Feedback
Accelerated adoption of telehealth and virtual care models, which can reduce the need for traditional medical office space for many routine consultations and diagnoses.
Increased shift towards home-based care and specialized outpatient settings, such as ambulatory surgical centers, for a growing array of medical procedures and long-term care, potentially diminishing demand for traditional inpatient facilities and skilled nursing facilities.
AI Analysis | Feedback
American Healthcare REIT (AHR) primarily invests in senior housing, skilled nursing facilities, and medical office buildings. The addressable markets for these main products or services in the U.S. are as follows:
- Senior Housing Market (U.S.): The U.S. senior living market was valued at approximately USD 111.20 billion in 2024 and is projected to reach around USD 201.03 billion by 2034, growing at a CAGR of 6.10% from 2025 to 2034. Another estimate placed the market at USD 125.44 billion in 2024, projected to reach USD 185.47 billion by 2032 with a CAGR of 5.01% from 2026 to 2032.
- Skilled Nursing Facility Market (U.S.): The U.S. skilled nursing facilities market size was estimated at USD 199.72 billion in 2024 and is expected to reach USD 290.02 billion by 2033, with a compound annual growth rate (CAGR) of 4.39% from 2025 to 2033. Another report estimates the market to be worth USD 202.4 billion in 2025, anticipated to reach USD 279.9 billion by 2035, at a CAGR of 3.3% over the forecast period.
- Medical Office Buildings Market (U.S.): The medical office buildings market in the United States generated an estimated revenue of USD 14.08 billion in 2023 and is expected to reach USD 22.04 billion by 2030, growing at a CAGR of 6.6% from 2024 to 2030. The U.S. market is estimated at $22.4 billion in 2024.
AI Analysis | Feedback
American Healthcare REIT (AHR) is expected to drive future revenue growth over the next 2-3 years through several key strategies and market dynamics:
- Strong Same-Store Net Operating Income (NOI) Growth in Senior Housing: A significant driver of revenue growth is anticipated from the company's existing portfolio, particularly its Senior Housing Operating Properties (SHOP) and Integrated Senior Health Campuses (ISHC) segments. American Healthcare REIT has reported and guided for substantial Same-Store NOI growth in these segments, with a 17.0% increase for the total portfolio in Q3 2024 compared to the same period in 2023, highlighted by 61.8% and 22.6% Same-Store NOI growth from its SHOP and ISHC properties, respectively. This trend continued into Q3 2025, with total portfolio Same-Store NOI growth of 16.4%, including 25.3% and 21.7% from SHOP and ISHC segments. Management has also increased full-year 2025 total portfolio Same-Store NOI growth guidance, primarily due to strong operating results in these segments.
- Strategic Acquisitions and External Growth: The company is actively pursuing and executing on external growth opportunities through acquisitions. American Healthcare REIT closed on approximately $210.8 million of acquisitions during Q3 2025, contributing to over $575 million in new acquisitions year-to-date 2025. The company has also highlighted a robust pipeline of investments, with awarded deals projected to close by year-end 2025, and plans for development and redevelopment starts, which are expected to further expand its revenue-generating asset base. This strategic expansion of its portfolio directly contributes to increased rental income and resident fees.
- Increasing Occupancy and Pricing Power in Senior Housing: Improved operational performance within the senior housing segments (SHOP and ISHC) is being driven by higher occupancy rates and a return of pricing power. The benefits of increased occupancy in higher-margin assisted living and memory care settings, coupled with strong demand for senior care due to favorable demographic trends, provide a solid foundation for sustained NOI and revenue growth.
- Stable, Contractual Rent Escalators from Triple-Net Leased Properties: While less dynamic than the senior housing segments, the company's triple-net leased assets, such as Medical Office Buildings (MOBs), offer a stable and predictable component of revenue growth. These properties typically feature contractual annual rent escalators, which generally range from 2% to 3%, providing a consistent, albeit modest, increase in rental income over time.
AI Analysis | Feedback
Share Repurchases
- American Healthcare REIT's Share Repurchase Plan (SRP) was suspended in April 2020, with exceptions only for requests due to death or qualifying disability.
- As of March 2022, repurchases were still limited to cases of death or qualifying disability.
- Following the company's listing on the NYSE in February 2024, the Share Repurchase Plan was discontinued as shares became freely tradable on the exchange.
Share Issuance
- In February 2024, American Healthcare REIT completed its Initial Public Offering (IPO), issuing 64.4 million shares at $12.00 per share, which included the full exercise of the underwriters' overallotment option, with net proceeds primarily used to repay approximately $717.6 million of outstanding debt.
- In September 2024, the company priced an upsized underwritten public offering of 17.4 million shares at $23.55 per share, granting underwriters an option to purchase an additional 2.61 million shares. The net proceeds from this offering were intended to acquire a 24% minority interest in Trilogy Holdings, LLC and to further repay debt.
- Through its At-the-Market (ATM) program, AHR issued 4.3 million shares for approximately $120.2 million in Q4 2024, 1.6 million shares for approximately $47.7 million in Q1 2025, and an additional 2.9 million shares for approximately $116.3 million in Q3 2025, alongside settling forward sales agreements for approximately $127.8 million in Q3 2025.
Inbound Investments
- The company's primary inbound investment event was its Initial Public Offering (IPO) in February 2024, which generated $672 million from the sale of 56 million shares at $12.00 per share. The net proceeds from the IPO were predominantly allocated to reducing outstanding debt.
Outbound Investments
- During 2024, American Healthcare REIT purchased over $650 million in new investments, including the acquisition of its joint venture partner's remaining 24% minority membership interest in Trilogy REIT Holdings for $258 million in Q3 2024, gaining full ownership of Trilogy.
- In Q1 2024, AHR acquired a 14-property portfolio in Oregon for approximately $94.5 million, and in Q2 2025, it acquired a new Senior Housing Operating Property (SHOP) asset for approximately $65.0 million and four long-term care assets within its Integrated Senior Health Campuses (ISHC) segment for approximately $65.3 million.
- The company actively manages its portfolio through dispositions, selling approximately $15.6 million in non-core properties in Q1 2024 and an outpatient medical building for $19.4 million, along with 10 additional properties for approximately $120.5 million in Q4 2024.
Capital Expenditures
- American Healthcare REIT has approved new Integrated Senior Health Campus (ISHC) development projects, including new campuses and expansions, with expected construction costs of approximately $136.6 million starting in 2025.
- As of September 30, 2025, the total in-process development and expansion pipeline was projected to cost approximately $176.9 million, with $51.8 million already expended.
- Accrued developments and capital expenditures amounted to $22.6 million as of December 31, 2024, and $20.7 million as of June 30, 2025.
Latest Trefis Analyses
Trade Ideas
Select ideas related to AHR. For more, see Trefis Trade Ideas.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 10312025 | MPW | Medical Properties Trust | Special | Short Squeeze PotentialShort Squeeze PotentialHas potential for a short squeeze. High short interest, rising short interest and high debt. | 1.1% | 1.1% | -5.8% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons for American Healthcare REIT
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 46.05 |
| Mkt Cap | 12.0 |
| Rev LTM | 2,500 |
| Op Inc LTM | 619 |
| FCF LTM | 922 |
| FCF 3Y Avg | 705 |
| CFO LTM | 1,059 |
| CFO 3Y Avg | 893 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 11.7% |
| Rev Chg 3Y Avg | 10.7% |
| Rev Chg Q | 11.1% |
| QoQ Delta Rev Chg LTM | 2.7% |
| Op Mgn LTM | 17.4% |
| Op Mgn 3Y Avg | 16.6% |
| QoQ Delta Op Mgn LTM | 0.1% |
| CFO/Rev LTM | 36.4% |
| CFO/Rev 3Y Avg | 34.6% |
| FCF/Rev LTM | 36.2% |
| FCF/Rev 3Y Avg | 34.3% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 12.0 |
| P/S | 6.2 |
| P/EBIT | 34.9 |
| P/E | 78.0 |
| P/CFO | 19.0 |
| Total Yield | 5.1% |
| Dividend Yield | 4.1% |
| FCF Yield 3Y Avg | 7.0% |
| D/E | 0.4 |
| Net D/E | 0.3 |
Segment Financials
Assets by Segment| $ Mil | 2024 | 2023 | 2022 |
|---|---|---|---|
| Integrated Senior Health Campuses (ISHC) | 2,198 | 2,158 | |
| Outpatient Medical (OM) | 1,232 | 1,380 | |
| Senior housing operating properties (SHOP) | 630 | 635 | |
| Triple-Net Leased Properties | 503 | ||
| Other | 15 | 13 | |
| Hospitals | 106 | ||
| Senior Housing - Leased | 250 | ||
| Skilled nursing facilities (SNFs) | 246 | ||
| Total | 4,578 | 4,787 |
Price Behavior
| Market Price | $48.50 | |
| Market Cap ($ Bil) | 8.2 | |
| First Trading Date | 02/07/2024 | |
| Distance from 52W High | -4.5% | |
| 50 Days | 200 Days | |
| DMA Price | $47.05 | $38.68 |
| DMA Trend | up | up |
| Distance from DMA | 3.1% | 25.4% |
| 3M | 1YR | |
| Volatility | 23.5% | 26.7% |
| Downside Capture | -27.75 | 1.95 |
| Upside Capture | 47.52 | 59.25 |
| Correlation (SPY) | -1.3% | 36.4% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | -0.06 | 0.03 | 0.10 | 0.10 | 0.52 | -0.08 |
| Up Beta | -0.20 | 0.25 | 0.39 | 0.55 | 0.62 | -0.06 |
| Down Beta | 0.12 | -0.38 | -0.54 | -0.30 | 0.67 | 0.07 |
| Up Capture | 89% | 85% | 74% | 59% | 49% | 21% |
| Bmk +ve Days | 12 | 25 | 38 | 73 | 141 | 426 |
| Stock +ve Days | 12 | 26 | 36 | 75 | 142 | 264 |
| Down Capture | -64% | -45% | -9% | -56% | 10% | 4% |
| Bmk -ve Days | 7 | 16 | 24 | 52 | 107 | 323 |
| Stock -ve Days | 7 | 15 | 25 | 48 | 104 | 184 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
nullBased On 5-Year Data
nullBased On 10-Year Data
nullReturns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 11/6/2025 | 3.1% | 0.7% | 3.2% |
| 8/7/2025 | 1.6% | 1.3% | 7.3% |
| 5/8/2025 | 8.4% | 8.6% | 9.3% |
| 11/12/2024 | 3.4% | 8.5% | 9.4% |
| 8/5/2024 | 6.4% | 9.4% | 39.1% |
| 3/21/2024 | -1.8% | 5.8% | -4.9% |
| SUMMARY STATS | |||
| # Positive | 5 | 6 | 5 |
| # Negative | 1 | 0 | 1 |
| Median Positive | 3.4% | 7.1% | 9.3% |
| Median Negative | -1.8% | -4.9% | |
| Max Positive | 8.4% | 9.4% | 39.1% |
| Max Negative | -1.8% | -4.9% | |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 9302025 | 11072025 | 10-Q 9/30/2025 |
| 6302025 | 8082025 | 10-Q 6/30/2025 |
| 3312025 | 5092025 | 10-Q 3/31/2025 |
| 12312024 | 2282025 | 10-K 12/31/2024 |
| 9302024 | 11132024 | 10-Q 9/30/2024 |
| 6302024 | 8092024 | 10-Q 6/30/2024 |
| 3312024 | 5142024 | 10-Q 3/31/2024 |
| 12312023 | 3222024 | 10-K 12/31/2023 |
| 9302023 | 11132023 | 10-Q 9/30/2023 |
| 6302023 | 8142023 | 10-Q 6/30/2023 |
| 3312023 | 5152023 | 10-Q 3/31/2023 |
| 12312022 | 3172023 | 10-K 12/31/2022 |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.